Literature DB >> 2364079

Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols.

D Collins1, D C Litzinger, L Huang.   

Abstract

The titratable, double-chain amphiphiles 1,2-dipalmitoyl-sn-3-succinylglycerol (1,2-DPSG), 1,2-dioleoyl-sn-3-succinylglycerol (1,2-DOSG) and 1,3-dipalmitoylsuccinylglycerol (1,3-DPSG) have been used in combination with phosphatidylethanolamine (PE) to form pH-sensitive liposomes. The effect of the compounds on dielaidoyl PE bilayer stabilization was examined by differential scanning calorimetry. Only 1,2-DPSG showed bilayer stabilization activity; whereas the other two are destabilizers at pH 7.4. All three amphiphiles became strong destabilizers at pH 5.0. The ability of the amphiphiles to stabilize DOPE liposomes was examined by light scattering and calcein entrapment. In general, 1,2-DPSG is the most potent stabilizer of PE bilayers while 1,3-DPSG is the weakest liposome stabilizer. All three compounds can be combined with DOPE to generate liposomes which are stable at neutral and basic pH. At weakly acidic pH, the liposomes are leaky and exhibit extensive lipid mixing, with protons and calcium showing synergistic effects on lipid mixing. DOPE/1,2-DPSG liposomes are stable in human plasma and remain acid-sensitive even after prolonged plasma incubation. Immunoliposomes prepared from either DOPE/1,2-DPSG or DOPE/1,2-DOSG can deliver diphtheria toxin A fragment to the cytoplasm of cultured cells in a process which involves endocytosis of the liposomes. Immunoliposomes prepared with 1,2-DPSG are more effective drug carriers than those prepared with 1,2-DOSG. These results indicate that the bilayer- and, hence the liposome-stabilization activity of the diacylsuccinylglycerol depends on the structure of the compounds. The potential drug delivery activity of the pH-sensitive liposomes composed of these lipids is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364079     DOI: 10.1016/0005-2736(90)90102-t

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

2.  Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy.

Authors:  Feihu Wang; Michael Porter; Alexandros Konstantopoulos; Pengcheng Zhang; Honggang Cui
Journal:  J Control Release       Date:  2017-09-25       Impact factor: 9.776

Review 3.  Membrane adhesion and the formation of heterogeneities: biology, biophysics, and biotechnology.

Authors:  V D Gordon; T J O'Halloran; O Shindell
Journal:  Phys Chem Chem Phys       Date:  2015-04-13       Impact factor: 3.676

Review 4.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

Review 5.  Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.

Authors:  Thomas L Andresen; David H Thompson; Thomas Kaasgaard
Journal:  Mol Membr Biol       Date:  2010-10-13       Impact factor: 2.857

Review 6.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

7.  Simultaneous delivery of Paclitaxel and Bcl-2 siRNA via pH-Sensitive liposomal nanocarrier for the synergistic treatment of melanoma.

Authors:  Teegala Lakshminarayan Reddy; Koteswara Rao Garikapati; S Gopal Reddy; B V Subba Reddy; J S Yadav; Utpal Bhadra; Manika Pal Bhadra
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

Review 8.  Vaccine development and technology for SARS-CoV-2: Current insight.

Authors:  Luigi Cattel; Susanna Giordano; Sara Traina; Tommaso Lupia; Silvia Corcione; Lorenzo Angelone; Giovanni La Valle; Francesco G De Rosa; Francesco Cattel
Journal:  J Med Virol       Date:  2021-11-11       Impact factor: 20.693

9.  Application of fusogenic liposomes containing fragment A of diphtheria toxin to cancer therapy.

Authors:  H Mizuguchi; M Nakanishi; T Nakanishi; T Nakagawa; S Nakagawa; T Mayumi
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Modification of fliposomes with a polycation can enhance the control of pH-induced release.

Authors:  Anastasia Yu Lokova; Olga V Zaborova
Journal:  Int J Nanomedicine       Date:  2019-02-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.